| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-09-18 | SCHEDULE 13G | GENERAL ATLANTIC, L.P. | — | — | view → |
| 2026-09-16 | SCHEDULE 13G | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | — | — | view → |
| 2026-09-15 | SCHEDULE 13D | Venrock Healthcare Capital Partners III, L.P. | 9.90% | 4,552,277 | view → |
| 2026-09-11 | SCHEDULE 13D | Fairmount Funds Management LLC | 19.99% | 9,103,729 | view → |
| 2026-07-20 | SCHEDULE 13D/A | Hecht Peter M | — | 910,240 | view → |
| 2023-05-23 | SC | Hecht Peter M | — | — | view → |
| 2023-05-12 | SC | Hecht Peter M | — | — | view → |
| 2023-04-03 | SC | Hecht Peter M | — | — | view → |
| 2022-11-21 | SC | Hecht Peter M | — | — | view → |
| 2021-06-07 | SC | Hecht Peter M | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-09-08 | SCHEDULE 13G | Tenax Therapeutics, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Rein Therapeutics, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Yarrow Bioscience, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | NextCure, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Editas Medicine, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | JATT II Acquisition Corp. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Amanat Acquisition Corp. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Boundless Bio, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Pliant Therapeutics, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13G | Research Alliance Corporation III | — | — | view → |
| 2026-06-05 | SCHEDULE 13G | InMed Pharmaceuticals, Inc. INM | — | — | view → |
| 2026-06-05 | SCHEDULE 13G | Rallybio Corporation RLYB | — | — | view → |
| 2025-04-28 | SCHEDULE | Keros Therapeutics, Inc. KROS | 13.29% | 5,390,964 | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →